Letters
The truth about Tamiflu?
Neuraminidase inhibitors in pandemic A/H1N1 flu
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c130 (Published 13 January 2010) Cite this as: BMJ 2010;340:c130
- J Todd Weber, on assignment from US Centers for Disease Control and Prevention1,
- Angus Nicoll, coordinator1,
- Carolyn B Bridges, associate director for science2,
- Bruno C Ciancio, senior expert1
- 1Influenza Programme, European Centre for Disease Prevention and Control (ECDC), 171 83 Stockholm, Sweden
- 2Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
- jtodd.weber{at}ecdc.europa.eu
Jefferson and colleagues describe the effectiveness of neuraminidase inhibitors in otherwise healthy adults infected with seasonal flu virus,1 but it is mainly the A/H1N1 flu virus that is currently in circulation.
Given the limited availability of vaccine against 2009 pandemic A/H1N1 flu, antiviral drugs have assumed a prominent role in reducing severe flu …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.